新冠疫情后的临床研究：拥抱新常态。
Clinical Research after COVID-19: Embracing a New Normal.
机构信息
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
出版信息
J Invest Dermatol. 2021 Mar;141(3):481-483. doi: 10.1016/j.jid.2020.08.004. Epub 2020 Sep 2.
The coronavirus disease 2019 (COVID-19) pandemic is a grave public health crisis, causing massive disruption to daily life. Dermatology clinical trials in psoriasis, atopic dermatitis, and hidradenitis have been suspended, terminated, or otherwise disrupted. Clinical investigators need to embrace a COVID-19 new normal and adjust research procedures to mitigate the risk of transmitting severe acute respiratory syndrome coronavirus 2 and depleting personal protective equipment while maintaining scientific rigor.
2019 冠状病毒病（COVID-19）大流行是一场严重的公共卫生危机，对日常生活造成了巨大干扰。银屑病、特应性皮炎和化脓性汗腺炎的皮肤病学临床试验已暂停、终止或其他方式受到干扰。临床研究者需要接受 COVID-19 新常态，并调整研究程序，以减轻传播严重急性呼吸综合征冠状病毒 2 和耗尽个人防护设备的风险，同时保持科学严谨性。
Zotero 插件